OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of genetic variants and host polymorphisms on COVID‐19: From viral entrance mechanisms to immunological reactions
Abolfazl Adli, Mandana Rahimi, Reza Khodaie, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1846-1865
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines
Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 32-49
Open Access | Times Cited: 44

Population-specific polymorphisms and SARS-CoV-2 infectivity
Nikita Jain, Shampa Chatterjee
Elsevier eBooks (2025), pp. 75-87
Closed Access

Precision management of post‐COVID pain: An evidence and clinical‐based approach
César Fernández‐de‐las‐Peñas, Jo Nijs, Rocco Giordano, et al.
European Journal of Pain (2023) Vol. 27, Iss. 9, pp. 1107-1125
Open Access | Times Cited: 13

Genetic mutations associated with severe respiratory diseases
Alexey D. Moshkin, Kristina A. Stolbunova, Alina D. Matsvay, et al.
South of Russia ecology development (2025) Vol. 19, Iss. 4, pp. 28-40
Open Access

Viral and immune profiles during the first wave of SARS-CoV-2 infection in hospitalized patients in Sardinia, Italy
Giulietta Venturi, Alessandra Gallinaro, Claudia Fortuna, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

DNA Salivary Methylation Levels of the ACE2 Promoter Are Not Related to ACE2 (rs2285666 and rs2074192), TMPRSS2 (rs12329760 and rs2070788) and ACE1 rs1799752 Polymorphisms in COVID-19 Survivors with Post-COVID-19 Condition
César Fernández‐de‐las‐Peñas, Gema Díaz‐Gil, Antonio Gil-Crujera, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2100-2100
Open Access

Harnessing Nanovaccines for Effective Immunization─A Special Concern on COVID-19: Facts, Fidelity, and Future Prospective
Amol D. Gholap, Juhi Gupta, Pallavi Kamandar, et al.
ACS Biomaterials Science & Engineering (2023) Vol. 10, Iss. 1, pp. 271-297
Closed Access | Times Cited: 11

IFNL1 rs30461 polymorphism as a risk factor for COVID-19 severity: A cross-sectional study
Maha O. Hammad, Mahmoud M. Alseoudy, Asmaa M. Borg, et al.
Cytokine (2024) Vol. 176, pp. 156500-156500
Closed Access | Times Cited: 3

Defective antifungal immunity in patients with COVID-19
Oliver Morton, James S. Griffiths, Juergen Loeffler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18

Predictive Factors and ACE-2 Gene Polymorphisms in Susceptibility to Long COVID-19 Syndrome
David Varillas‐Delgado, Carmen Jiménez‐Antona, Angel Lizcano‐Álvarez, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16717-16717
Open Access | Times Cited: 10

Sex‐specific disparities in COVID‐19 outcomes
Zubaid Rafique, Valerie Durkalski‐Mauldin, W. Frank Peacock, et al.
Journal of the American College of Emergency Physicians Open (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 2

Are Pain Polymorphisms Associated with the Risk and Phenotype of Post-COVID Pain in Previously Hospitalized COVID-19 Survivors?
César Fernández‐de‐las‐Peñas, Rocco Giordano, Gema Díaz‐Gil, et al.
Genes (2022) Vol. 13, Iss. 8, pp. 1336-1336
Open Access | Times Cited: 11

Relevance of HLA-DP/DQ and INF-λ4 Polymorphisms to COVID-19 Outcomes
Amany A. Ghazy, Abdullah N. Al‐Rasheedi, Mohammed Elashri, et al.
British Journal of Biomedical Science (2023) Vol. 80
Open Access | Times Cited: 6

Innate Immune Gene Polymorphisms and COVID-19 Prognosis
Evangelos Bakaros, Ioanna Voulgaridi, Vassiliki Paliatsa, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1784-1784
Open Access | Times Cited: 6

Its all about IFN‐λ4: Protective role of IFNL4 polymorphism against COVID‐19‐related pneumonia in females
Sanja Matić, Dragan Milovanović, Željko Mijailović, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 10
Open Access | Times Cited: 6

ACE1 rs1799752 polymorphism is not associated with long-COVID symptomatology in previously hospitalized COVID-19 survivors
César Fernández‐de‐las‐Peñas, Lars Arendt‐Nielsen, Gema Díaz‐Gil, et al.
Journal of Infection (2022) Vol. 86, Iss. 3, pp. e67-e69
Open Access | Times Cited: 8

Immunogenicity and adverse events of the COVID-19 vaccines in healthy and individuals with autoimmune diseases in an Iranian population
Amin Moradi Hasan‐Abad, Mohsen Arbabi, Hamidreza Gilasi, et al.
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access | Times Cited: 1

Neurological Sequelae of Post-COVID-19 Fatigue: A Narrative Review of Dipeptidyl Peptidase IV-Mediated Cerebrovascular Complications
Che Mohd Nasril Che Mohd Nassir, Muhammad Danial Che Ramli, Usman Jaffer, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 13565-13582
Open Access | Times Cited: 1

Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia
Diana Cadena Castaneda, Sonia Jangra, Marina Yurieva, et al.
iScience (2023) Vol. 26, Iss. 8, pp. 107374-107374
Open Access | Times Cited: 4

The effect of diabetes on COVID-19 incidence and mortality: Differences between highly-developed-country and high-migratory-pressure-country populations
Marta Ottone, Letizia Bartolini, Laura Bonvicini, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 3

The polymorphisms of TNF-α related-gene and antibody production following third dose of COVID-19 vaccination: A pilot study
Phey Liana, Zen Hafy, Soilia Fertilita, et al.
Vacunas (2023) Vol. 24, Iss. 4, pp. 273-277
Open Access | Times Cited: 3

SARS-CoV-2 and extracellular vesicles: An intricate interplay in pathogenesis, diagnosis and treatment
Caterina Sbarigia, Diana Vardanyan, Luca Buccini, et al.
Frontiers in Nanotechnology (2022) Vol. 4
Open Access | Times Cited: 5

Association between IL-6 rs1800795 and IL-1β rs 16944 gene polymorphisms with clinical severity of COVID-19 patients in Surakarta, Central Java, Indonesia
Hendrastutik Apriningsih, Betty Suryawati, Reviono Reviono, et al.
Bali Medical Journal (2023) Vol. 12, Iss. 1, pp. 904-908
Open Access | Times Cited: 2

Mass versus personalized medicine against COVID ‐19 in the “system sciences” era
Laura Teodori, Barbara Osimani, Ciro Isidoro, et al.
Cytometry Part A (2022) Vol. 101, Iss. 12, pp. 995-999
Open Access | Times Cited: 3

COVID-19 pandemic to endemic
Razdan Alpana, Arora Rajat, Agarwal Gauri, et al.
International Journal of Clinical Virology (2022) Vol. 6, Iss. 2, pp. 043-049
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top